menu
    • menu

    Company profile for The Ritedose Corporation

    NEW Drugs in Dev: 3
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ritedose was affiliated with Holopack International, a subsidiary of the German-based Hansen Group, inventor of BFS technology under the Rommelag® brand. Their decades of experience have made them a worldwide leader in this field. Combined with our manufacturing experience, it is the springboard for our future as the leading innovator of unit dose liquid pharmaceutical delivery systems. In 2009 Ritedose was acquired by a p...
    Ritedose was affiliated with Holopack International, a subsidiary of the German-based Hansen Group, inventor of BFS technology under the Rommelag® brand. Their decades of experience have made them a worldwide leader in this field. Combined with our manufacturing experience, it is the springboard for our future as the leading innovator of unit dose liquid pharmaceutical delivery systems. In 2009 Ritedose was acquired by a private equity firm, Olympus Partners from Stamford, CT.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    The Ritedose CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Carolina Research Park, 1 Technology Circle, Columbia, SC 29203, USA
    Telephone
    Telephone
    803-806-3300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ritedose.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ritedose, USC Host Top European Students in Advanced Program
    Ritedose, USC Host Top European Students in Advanced Program

    23 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/23/3279939/0/en/ritedose-university-of-south-carolina-welcome-top-european-business-students-for-immersive-learning-about-advanced-manufacturing.html

    GLOBENEWSWIRE
    23 Apr 2026
    Share Share
    Ritedose to Manufacture Tenpoint's Presbyopia Eye Drops
    Ritedose to Manufacture Tenpoint's Presbyopia Eye Drops

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3270117/0/en/Ritedose-Announces-Manufacturing-for-Tenpoint-Therapeutics-Presbyopia-Eye-Drop.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    Ritedose Gets FDA Nod For Generic Tobramycin Inhalation Solution
    Ritedose Gets FDA Nod For Generic Tobramycin Inhalation Solution

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177385/0/en/Ritedose-Now-Offers-the-Largest-Nebulized-Drug-Portfolio-in-the-U-S-FDA-Approves-the-Company-to-Manufacture-Generic-Tobramycin-Inhalation-Solution.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Ritedose Corp. to Invest $17 Million in Laboratory Expansion
    Ritedose Corp. to Invest $17 Million in Laboratory Expansion

    24 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/24/3155438/0/en/Leading-CDMO-Enhances-cGMP-Lab-Infrastructure-to-Strengthen-Position.html

    GLOBENEWSWIRE
    24 Sep 2025
    Share Share
    Ritedose Reveals New Distribution Facility at Performance Park
    Ritedose Reveals New Distribution Facility at Performance Park

    18 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ritedose-unveils-state-of-the-art-distribution-and-logistics-facility-at-ritedose-performance-park-302485712.html

    PR NEWSWIRE
    18 Jun 2025
    Share Share
    Ritedose Pharmaceuticals FDA Approve Albuterol Sulfate Inhalation
    Ritedose Pharmaceuticals FDA Approve Albuterol Sulfate Inhalation

    20 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ritedose-pharmaceuticals-receives-fda-approval-for-albuterol-sulfate-inhalation-solution-0-5-2-5-mg0-5-mladdressing-nationwide-shortage-of-the-essential-drug-302459668.html

    PR NEWSWIRE
    20 May 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search